LADENBURG THALMANN FINANCIAL SERVICES INC. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 106 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 2.19 and the average weighting 0.8%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q4 2019$4,000
+33.3%
1380.0%0.00%
Q3 2019$3,000
+50.0%
1380.0%0.00%
Q2 2019$2,000
-33.3%
1380.0%0.00%
Q1 2019$3,0000.0%138
+17.9%
0.00%
Q4 2018$3,000
+200.0%
117
+588.2%
0.00%
Q3 2018$1,000170.0%0.00%
Q2 2018$0170.0%0.00%
Q1 2018$0170.0%0.00%
Q4 2017$0
-100.0%
170.0%0.00%
Q3 2017$1,0000.0%170.0%0.00%
Q2 2017$1,0000.0%170.0%0.00%
Q1 2017$1,0000.0%170.0%0.00%
Q4 2016$1,0000.0%170.0%0.00%
Q3 2016$1,000170.0%0.00%
Q2 2016$0170.0%0.00%
Q1 2016$0170.0%0.00%
Q4 2015$0170.0%0.00%
Q3 2015$017
-34.6%
0.00%
Q2 2015$0260.0%0.00%
Q1 2015$026
+52.9%
0.00%
Q4 2014$0170.0%0.00%
Q3 2014$0170.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,269,584$69,497,223,00012.98%
Newtyn Management, LLC 1,375,000$13,145,0003.15%
Chescapmanager LLC 1,166,574$11,152,0001.51%
Baupost Group 13,643,333$130,430,0001.40%
Weiss Asset Management LP 5,412,487$51,743,0001.07%
CM Management, LLC 120,000$1,147,0000.96%
Orbimed Advisors 3,254,713$31,115,0000.50%
King Wealth Management Group 122,000$1,166,0000.23%
Woodline Partners LP 1,326,653$12,683,0000.21%
PDT Partners, LLC 192,701$1,842,0000.16%
View complete list of THERAVANCE BIOPHARMA INC shareholders